Follow the progress of Hemolens Diagnostics
This website contains information intended only for persons professionally dealing with medical devices (e.g. for persons performing medical professions, for persons dealing with the distribution of medical devices). Please confirm that you are a medical device professional to proceed.
Follow the progress of Hemolens Diagnostics
August 12, 2022
A privilege and an honor. Hemolens Diagnostics has received an invitation to participate in the Global Healthcare Roundtable at Microsoft Inspire 2022.
This year’s topic debate was to determine the answer to the question:
“How can Microsoft support the existing efforts of its partners in the healthcare industry, so that together we can increase the popularity and use of these services and Microsoft tools?”
The meeting were moderated by Nick Parker (President, Industry & Partners – Microsoft), accompanied by Julie Sanford, Tom McGuinness and Satish Thomas – key experts within Microsoft.
Only selected Microsoft partners, leaders among innovative companies providing Healthcare technology solutions from the US and Europe, have been granted the privilage of participating in a virtual roundtable discussion.
Hemolens Diagnostics received the distinction of being the only Eastern European Partner to develop arguably the most accurate technology based on Computational Fluid Dynamics (CFD) for coronary artery diagnostics.
Wojciech Jeżewski, CEO of Hemolens Diagnostics commented: “Our main purpose was to address topics important for accelerating the development and expansion of med-tech companies, such as building the trust of patients, doctors and institutions in 100% cloud-based products in the context of ensuring the privacy of medical data, or the development of new technologies and related challenges.”
Intended Use:
Cardiolens FFR-CT Pro is a coronary physiologic simulation software for the clinical quantitative and qualitative analysis of previously acquired Coronary Computed Tomography Angiography (CCTA) and optionally with Continuous Non-invasive Blood Pressure (CNBP) data for assessment of patients with suspected Chronic Coronary Syndromes (CCS). It provides hemodynamic diagnostic factor FFR-CT (Fractional Flow Reserve with Computed Tomography), a mathematically derived quantity, computed from simulated pressure, velocity and blood flow information obtained from a 3D computer model generated from static coronary CT images and optionally from CNBP measurement. The factor FFR-CT at the output of Cardiolens FFR-CT Pro device is intended to support the functional evaluation of coronary artery disease. The Cardiolens FFR-CT Pro outputs are provided to support qualified clinicians to aid in the evaluation and assessment of coronary arteries. The results of Cardiolens FFR-CT Pro are intended to be used by qualified clinicians in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgment.